In her book, “Bottle of Lies: The Inside Story of the Generic Drug Boom,” Eban reveals how generic drug makers not only help ensure that some of the worst quality drugs enter the least regulated markets but also take extreme measures to avoid regulatory scrutiny. Harper Collins/Ecco’s Hardcover division published the book on May 14. Continue reading
A panel of experts in geriatric care has identified nearly 100 medications that should be avoided or used with caution among the older population in the latest update to the Beers Criteria for Potentially Inappropriate Medication Use in Older Adults.
The recommendations by the American Geriatrics Society are widely used by clinicians, educators, researchers, health care administrators and regulators to ensure medications are appropriately prescribed. Continue reading
In one study, Greg Rhee, Ph.D., an adjunct assistant professor in the University of Minnesota College of Pharmacy, examined prescribing trends in outpatient settings of opioids and benzodiazepines. His analysis found that between 2006-07 and 2014-15, the prescription rates of benzodiazepine drugs such as Xanax and Halcion increased from 4.8 percent to 6.2 percent; the rate of prescription opioids alone increased from 5.9 percent to 10 percent, and the co-prescribing rate of both benzodiazepines and opioids increased over time from 1.1 percent to 2.7 percent, respectively. Continue reading
In April, the staff of the Cincinnati Enquirer won the 2018 Pulitzer Prize in Local Reporting for an extraordinary special project, “Seven Days of Heroin: This is what an epidemic looks like.” As the Pulitzer judges said, the newspaper’s staff won, “For a riveting and insightful narrative and video documenting seven days of greater Cincinnati’s heroin epidemic, revealing how the deadly addiction has ravaged families and communities.” The project’s video element earned an Edward R. Murrow award for excellence in video and a regional Emmy award. Continue reading
WebMD investigative reporter Brenda Goodman and Georgia Health News CEO Andy Miller began their investigation late last year after Miller received a tip about a Georgia resident who owed more than $10,000 for her treatment. Continue reading
Alzheimer’s disease is the sixth leading cause of death in the U.S. Despite decades of research, there’s still no cure, and few options to slow or minimize symptoms. The last Alzheimer’s drug was approved more than 15 years ago, but a new campaign, called Disrupting Dementia, hopes to drive new diagnostics and treatments while also supporting patients and families affected by this devastating condition.